| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9945391 | The Annals of Thoracic Surgery | 2005 | 7 Pages |
Abstract
The Bravo Cardiovascular Model 400 stentless xenograft has provided good clinical and hemodynamic results up until 11 years of follow-up.
Keywords
ASAPWTTIAIVSTNYHALVMLVMIEOAacetylsalicylic acidNew York Heart Associationcoronary artery bypass graftinganalysis of varianceANOVACABGLeft ventricular masstransient ischemic attackLeft ventricular mass indexposterior wall thicknessInterventricular septal thicknesseffective orifice areaaortic insufficiencyejection fraction
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gianluca MD, Fabio MD, Luca MD, Manuela MD, Massimo MD, Andrea MD, Paolo MD,